PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 690580

Polio immunization: benefits and risks.

H V Wyatt
View original source ↗Export metadata ↓

Abstract

There are epidemiological as well as legal risks to polio immunization. The physician should compare the risks of vaccination with the risks which attend nonvaccination. Another view of the incidence of paralysis following oral poliovaccine (OPV) shows that the risk is about 1.6 cases per 10(6) nonimmune children given OPV and that this rises to about ten cases per 10(6) nonimmune adults exposed to OPV. There is little evidence of reversion to virulence of the virus and it is proposed that susceptibility of vaccinees and contacts to OPV is genetic. The risk of contracting poliomyelitis from either vaccine or wild virus rises about tenfold from the age of about three years to about ten years and thereafter remains constant. The risk of vaccinating children must be balanced against a tenfold risk of vaccinating when older and against a very much higher risk of paralysis or death from a wild virus. Present vaccination policies have virtually eliminated wild virus from the United States but have left many nonimmunes. The consequences of reintroduction of wild virus are examined, and the legal implications of genetic susceptibility are briefly discussed.

Explore related subjects

Disease OutbreaksHumansImmunityJurisprudenceParalysisPoliomyelitisPoliovirus Vaccine, OralRiskUnited StatesVaccinationVirulenceJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H V Wyatt. 1978. Polio immunization: benefits and risks.. https://pubmed.ncbi.nlm.nih.gov/690580/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Methods for cost-efficient, whole genome sequencing surveillance for enhanced detection of outbreaks in a hospital setting.

INTRODUCTION: Outbreaks of healthcare-associated infections (HAI) result in substantial patient morbidity and mortality; mitigation efforts by infection prevention teams have the potential to curb outbreaks and prevent transmission to additional patients. The incorporation of whole genome sequencing (WGS) surveillance of suspected high-risk pathogens often identifies outbreaks that are not detected by traditional infection prevention methods and provides evidence for transmission. Our approach to real-time WGS surveillance, the Enhanced Detection System for Healthcare-Associated Transmission (EDS-HAT), has 1) identified serious outbreaks that were otherwise undetected and 2) shown the potential to be cost saving. METHODS: We describe our cost-efficient methods to perform WGS surveillance and data analysis of pathogens for institutions that are interested in expanding infection prevention surveillance. We provide an overview of the weekly workflow of EDS-HAT during two distinct phases over three years. RESULTS: In an average week at our tertiary healthcare system, we sequenced 60 samples at a cost of less than $100 each during Phase 1, and 80 samples for less than $70 each in Phase 2, inclusive of laboratory reagents and staff salaries. The average turnaround time, from sample collection to reporting data to infection prevention, was nine days. CONCLUSIONS: Performing EDS-HAT in real-time can be both feasible and time-efficient. Providing such timely information to aid in outbreak detection could identify transmission events sooner and thus could increase patient safety.

Disease Outbreaks↗
PubMed2026

Deciphering the etiology of the 2024 outbreak of undiagnosed febrile illness in Panzi, Democratic Republic of the Congo.

In late 2024, an outbreak of over 400 cases of undiagnosed febrile illness, predominantly presenting as fever and cough, was reported in Panzi Health Zone, southwestern Democratic Republic of the Congo. Here we conducted an epidemiological and laboratory investigation to determine the etiology of the outbreak. Clinical data and specimens were prospectively collected from 108 individuals, of whom 59/108 (54.6%) were female. Children aged <5&#x2009;years were the most affected (47/108, 43.5%); 14/32 (43.7%) were malnourished. Oro/nasopharyngeal swabs from 96/108 individuals were PCR tested; 26 blood samples were sequenced. Plasmodium falciparum was detected in 56/108 (51.8%) individuals. Co-infections were also detected, with influenza A(H1N1)pdm09 virus in 16/56 (28.6%) and severe acute respiratory syndrome coronavirus 2 in 10/56 (17.9%) individuals. No novel pathogens were detected via metagenomics. Our findings suggest that the outbreak was primarily associated with a surge in malaria cases, with concurrent viral respiratory infections. Increasing decentralized laboratory capacity and strengthening broader health systems remain crucial for faster outbreak detection and investigation.

Disease Outbreaks↗
PubMed1992

Methodological problems in investigating disease clusters.

Increased reporting of disease clusters is stretching health department resources while failing to uncover many significant environmental hazards. By reviewing the methodology by which health departments respond to such reports, we argue that there is a strong bias against investigating the most hazardous situations. Failure to find serious hazards is more a reflection of the methodology used than an assessment of the existence of environmental problems. The biases arise from the selection of situations that dictate full in-house consideration, the selection of the methodology used to evaluate reported or registry-based data, and the interpretation given to anomalous observations. We argue for more rigorous evaluation of statistical cluster detection methods and for use of more objective criteria in cluster investigation protocols.

Disease Outbreaks↗